ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.580
-0.080 (-3.01%)
Jun 23, 2026, 5:35 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €41.46 million as of June 23, 2026. Its market cap has decreased by -52.79% in one year.
Market Cap
41.46M
Enterprise Value
42.39M
Revenue
7.97M
Ranking
n/a
PE Ratio
43.00
Stock Price
€2.58
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 41.46M, an increase of 1,553.01%. That is a compound annual growth rate of 11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 41.46M | -14.24% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.98B |
| EssilorLuxottica Société anonyme | 79.79B |
| Sartorius Stedim Biotech | 15.89B |
| Ipsen | 12.85B |
| MaaT Pharma | 53.80M |
| Theraclion | 51.18M |
| THX Pharma Société Anonyme | 47.46M |
| Fermentalg | 46.21M |